advertisement
11.4 Prostaglandins (63)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins74581 Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications
Shen J
Clinical Ophthalmology 2017; 11: 1761-1767
74735 Latanoprost-induced Skin Depigmentation
Lin M
Journal of Glaucoma 2017; 26: e246-e248
74295 Efficacy and safety of bimatoprost in glaucoma and ocular hypertension in non-responder patients
Brennan N
International Journal of Ophthalmology 2017; 10: 1251-1254
74071 Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study
Rolle T
BMC Ophthalmology 2017; 17: 136
74524 Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study
Takemoto D
Clinical Ophthalmology 2017; 11: 1617-1624
74244 Prostaglandin-associated periorbitopathy
Zhang F
Chinese Journal of Ophthalmology 2017; 53: 637-640
74131 Conjunctival Bacteria Flora of Glaucoma Patients During Long-Term Administration of Prostaglandin Analog Drops
Ohtani S
Investigative Ophthalmology and Visual Science 2017; 58: 3991-3996
74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Tokuda N
Journal of Ophthalmology 2017; 2017: 3540749
74127 Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% - an observational switch study
Deshpande SS
Clinical Ophthalmology 2017; 11: 1371-1376
74332 A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension
Dixon ER
Journal of AAPOS 2017; 21: 370-374.e1
74482 The Glaucoma Italian Pediatric Study (GIPSy): 1-Year Results
Quaranta L
Journal of Glaucoma 2017; 26: 987-994
74587 The Effect of Latanaprost on Intraocular Inflammation and Macular Edema
Razeghinejad MR
Ocular Immunology and Inflammation 2017; 0: 1-8
74332 A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension
Landry T
Journal of AAPOS 2017; 21: 370-374.e1
74482 The Glaucoma Italian Pediatric Study (GIPSy): 1-Year Results
Biagioli E
Journal of Glaucoma 2017; 26: 987-994
74524 Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study
Higashide T
Clinical Ophthalmology 2017; 11: 1617-1624
74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Kitaoka Y
Journal of Ophthalmology 2017; 2017: 3540749
74127 Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% - an observational switch study
Sonty S
Clinical Ophthalmology 2017; 11: 1371-1376
74071 Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study
Spinetta R
BMC Ophthalmology 2017; 17: 136
74581 Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications
Goodkin ML
Clinical Ophthalmology 2017; 11: 1761-1767
74244 Prostaglandin-associated periorbitopathy
Liao S
Chinese Journal of Ophthalmology 2017; 53: 637-640
74131 Conjunctival Bacteria Flora of Glaucoma Patients During Long-Term Administration of Prostaglandin Analog Drops
Shimizu K
Investigative Ophthalmology and Visual Science 2017; 58: 3991-3996
74295 Efficacy and safety of bimatoprost in glaucoma and ocular hypertension in non-responder patients
Dehabadi MH
International Journal of Ophthalmology 2017; 10: 1251-1254
74735 Latanoprost-induced Skin Depigmentation
Schmutz M
Journal of Glaucoma 2017; 26: e246-e248
74524 Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study
Saito Y
Clinical Ophthalmology 2017; 11: 1617-1624
74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Matsuzawa A
Journal of Ophthalmology 2017; 2017: 3540749
